Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
The goal of the current study was to assess the potential role of anxiety and depression on pain catastrophizing in older adults with chronic pain.
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
Exposure to maternal polycystic ovary syndrome is associated with increased risk of a range of neurodevelopmental and psychiatric disorders in offspring.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
Researchers explored provider screening practices in primary care, women’s health, and well-child clinics to determine if barriers exist in meeting postpartum depression screening guidelines.
Dexmedetomidine is currently available as a solution for intravenous infusion for use in clinical anesthesia and sedation in an intensive care setting.
There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.
Mothers who have children with MS have a higher prevalence of physical conditions, as well as a higher prevalence of mood and anxiety disorders.